PVLA
Palvella Therapeutics, Inc.
There isn't enough reported data to score PVLA yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
PVLA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
PVLA's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
PVLA PE Valuation
PVLA has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
PVLA Forward outlook
There aren't enough analyst estimates for PVLA to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
PVLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$12.97 | +$14.97 |
| Q2 2024 | -$19.58 | +$9.96 |
| Q1 2024 | -$12.82 | +$31.92 |
| Q4 2023 | -$23.27 | +$12.67 |
| Q3 2023 | -$27.94 | +$11.26 |
| Q2 2023 | -$29.54 | +$18.46 |
| Q1 2023 | -$44.74 | +$12.06 |
| Q4 2022 | -$35.94 | +$20.86 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 142% for PVLA versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
PVLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2024 | $53K | -97% |
| Q4 2023 | $1.3M | -78% |
| Q3 2023 | $19.5M | +264% |
| Q2 2023 | $20.1M | +442% |
| Q1 2023 | $1.9M | -82% |
| Q4 2022 | $5.8M | -31% |
| Q3 2022 | $5.4M | +32% |
| Q2 2022 | $3.7M | +13% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for PVLA versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2024 | -10006% | -9205 points |
| Q4 2023 | -347% | -150 points |
| Q3 2023 | -60% | +166 points |
| Q2 2023 | 10% | +344 points |
| Q1 2023 | -801% | -733 points |
| Q4 2022 | -197% | -67 points |
| Q3 2022 | -227% | +242 points |
| Q2 2022 | -333% | +177 points |
PVLA's operating margin was −10006% last quarter, down 9204 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
PVLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.4M | -$6.6M |
| Q2 2026 | -$12.8M | -$7.4M |
| Q1 2026 | -$10.9M | -$4.1M |
| Q4 2025 | -$4.9M | -$2.4M |
| Q3 2025 | -$7.9M | -5496% |
| Q2 2025 | -$5.4M | -$4M |
| Q1 2025 | -$6.8M | +$228K |
| Q4 2024 | -$2.5M | +$17.1M |
PVLA has burned cash in almost every quarter: −$43M over the past year, against −$23M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over PVLA on cash generation, producing positive trailing cash flow while its opponent burns cash.
PVLA Net Leverage
PVLA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
PVLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.2 | Neutral |
| Stochastic | 73.5 | Neutral |
PVLA's weekly RSI is 55 (neutral) and its Stochastic is 73 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
PVLA PE vs Healthcare Sector
PVLA has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
PVLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $141.3 | 8.4% above |
| 20 week MA | $146.0 | 4.9% above |
| 50 week MA | $124.4 | 23% above |
| 100 week MA | $81.0 | 89% above |
| 200 week MA | $56.7 | 170% above |
PVLA has the edge over UNH on trend strength, trading above more of its moving averages.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
PVLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $265.6 | $219.2 | -17% |
| 2021 | $219.2 | $293.6 | +34% |
| 2022 | $293.6 | $72.8 | -75% |
| 2023 | $72.8 | $14.6 | -80% |
| 2024 | $14.6 | $12.0 | -18% |
| 2025 | $12.0 | $103.4 | +761% |
| 2026 YTD | $103.4 | $153.2 | +48% |
PVLA has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.